AzTrials
AzTrials

HealthyNCT01290588

Aqueous Humor Dynamics and Biometric Parameters in Eyes of Children

An observational study of Healthy, run by University of Nebraska at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the effect of age and ethnic background on ocular aqueous humor dynamics and biometric parameters. Data of normal healthy children and adults will be used as controls for future study of juvenile glaucoma, and diabetes and potentially for any other condition that affects… Read more about this study

Who is it for?
Ages 15 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
How many people
53 participants
Where
1 siteUnited States
Study dates
1 Jun 2013to 25 Mar 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: * Children * Adults

Who may be able to join

  • Subjects must not have any ocular diseases
  • Children, 15 - 18 years of age
  • Adults, 30 - 50 years of age

Who cannot join

  • Women who are pregnant or lactating
  • Aphakia or pseudophakia
  • Chronic or recurrent severe ocular inflammatory disease.
  • Ocular infection or inflammation within three (3) months of screening visit.
  • History of clinically significant or progressive retinal disease such as retinal degeneration, diabetic retinopathy or retinal detachment.
  • Any abnormality preventing reliable tonometry of either eye.
Show all 15Show fewer
  • History of any ocular pathology (including dry eye).
  • A cup-to-disc ratio greater than 0.8
  • History of intraocular surgery
  • History of ocular laser surgery
  • History of hypersensitivity or allergy to beta blockers and sulfa drugs.
  • History of severe, unstable or uncontrolled cardiovascular, hepatic or renal disease.
  • History of bronchial asthma or chronic obstructive pulmonary disease (COPD).
  • Inability to discontinue contact lens wear.
  • Diagnosis of ocular hypertension or glaucoma or any ocular disease

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Nebraska Medical Center, Department of Ophthalmology and Visual Sciences

    Omaha, Nebraska, 68198-5540

Other trials in United States

About this study

The purpose of this study is to determine the effect of age and ethnic background on ocular aqueous humor dynamics and biometric parameters. Data of normal healthy children and adults will be used as controls for future study of juvenile glaucoma, and diabetes and potentially for any other condition that affects intraocular pressure in children.

Read the detailed description

Glaucoma is a progressive optic neuropathy and a leading cause of blindness in the United States1 and the second leading cause of blindness worldwide. In glaucoma, vision is lost through apoptosis of retinal ganglion cells. Diagnosis of glaucoma is usually based on a combination of progressive, characteristic vision loss (measured using visual field testing) and progressive optic nerve head damage (as detected through dilated fundus examinations or optic disc photography). While ocular hypertension (OHT) is not sufficient for a diagnosis of glaucoma, it is the greatest prognostic and modifiable factor. In fact, the only effective treatment for glaucoma currently is to treat the elevated IOP. This treatment does not provide a cure but it does slow glaucoma progression. IOP is determined by the balance between aqueous production (flow) and aqueous humor outflow through either the trabecular meshwork or uveoscleral pathway. Therefore, all clinically available glaucoma treatments are designed to increase drainage and/or reduce production. The main purpose of the current study is the determination of aqueous humor dynamics.

There are two main types of glaucoma, "open angle" or chronic glaucoma and "closed angle" or acute glaucoma. Open angle glaucoma tends to progress slowly and may remain undetected until the patient notices a change in vision. On the other hand, angle closure glaucoma appears suddenly and can be very painful, therefore is often diagnosed more quickly. The chance of suffering from either one of these types of glaucoma depends greatly on one's ethnic background. People suffering from primary angle-closure glaucoma (PACG) have short axial lengths and shallow anterior chambers. These physical dimensions are found predominantly in people from Asia and India. Angle-closure glaucoma is caused by factors that either pull or push the iris up into the angle, physically blocking the drainage of aqueous humor and increasing the resistance to outflow. The IOP will increase to dangerous levels in order to drain the fluid through the obstructed outflow pathways.

Narrow angles are not present in children. As a person ages, the lens of the eye continues to grow. In some but not all people, this growth pushes the iris forward, narrowing the angle. Risk factors for developing narrow angles include Asian ethnicity, hyperopia, family history, and advanced age. Prevalence figures identify East Asia as home to the majority of those affected by PACG. PACG is acknowledged as a major cause of ocular morbidity in Chinese populations and is more common among Chinese people than among Caucasian people. Part of the global project is to travel to China to study Chinese children and adults. This will be done in collaboration with Ganzu Hospital in Lanzhou, China. This is not part of the current protocol.

Open angle glaucoma typically occurs in older patients in the sixth decade of life or more. African-Americans have up to six times higher risk of developing the condition than the general population especially if there is a family history of glaucoma. Additionally, patients who are highly myopic, have diabetes mellitus, or have cardiovascular problems are at high risk of developing open angle glaucoma. Visual acuity, axial length and medical history will be collected as part of the current protocol.

Unlike narrow angle glaucoma, patients with open angle glaucoma have a gradual blockage of aqueous humor outflow despite a seemingly open chamber angle in the drainage pathway. As the eye ages, the drainage system can become clogged with debris causing pressure inside the eye to build to harmful levels. Open angle glaucoma can develop gradually and remain undetected for years. Because there is usually no pain experienced over the months or years of development and no other symptoms are apparent, the patient is often unaware of the existence of this serious eye disorder. Since African-Americans are at such a high risk for contracting glaucoma, children and adults of this ethnic background will be included in this study.

Glaucoma can occur in children as well as adults. Glaucoma that begins before the child is 3 years old is called infantile or congenital glaucoma. Glaucoma manifesting itself in a child's teens is juvenile glaucoma. There are many causes of childhood glaucoma, such as heredity, or injury or certain eye disorders. Once the investigators collect information on aqueous humor dynamics in healthy teenaged children, the investigators will study children of the same age with glaucoma. The investigators are planning to conduct these studies at Paracelsus University in Salzburg Austria. That is not part of the present protocol.

In the recent rabbit study, the investigators have learned that there are distinctive circadian rhythms of IOP and aqueous humor dynamics in juvenile and adult rabbits. In the ongoing clinical study of ocular hypertensive patients, the investigators are finding that some glaucoma medications are not effective at night despite being efficacious during the day. This has significant clinical importance. The investigators are including the study of aqueous humor dynamics at night in the current protocol to determine the normal circadian patterns for each ethnic group and age group.

In animal studies, the investigators have found that there are several significant differences in aqueous humor dynamics in immature animals compared to adult animals. This is not just a continuum of changes occurring between young and old adults. The investigators predict that important changes also take place in the ocular fluid dynamics of the eye as a child matures. The major changes may occur during puberty. Understanding normal ocular physiology in children will help us to understand the pathological changes taking place in juvenile glaucoma. The clinical importance of this project is immense

Conditions
Healthy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01290588
Study groupRoleWhat they receive
Children of Caucasian descentHealthy children of Caucasian descent.
Adults of Caucasian descentHealthy adult eyes of Caucasian descent.
Children of African-American descentHealthy children of African-American descent.
Adults of African-American descentHealthy adults of African-American descent.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Feb 2011 (estimated)
  2. Study start1 Jun 2013
  3. Primary completion25 Mar 2022
  4. Study completion25 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
53 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01290588
Sponsor's protocol ID
0364-09-FB
Status last verified
Sep 2023
First submitted
3 Feb 2011
Last updated
29 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy, run by University of Nebraska at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in